Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 3 results for "eisai"

Biocon to sell Parit in India after Eisai ends 12-year partnership with GSK
Money Control

Biocon to sell Parit in India after Eisai ends 12-year partner...

Biocon’s push in a crowded segment is viewed as interesting considering that in the last two years, the company has consciously moved out of products that have seen fierce competition. Money Control, 2 months ago

44 images for eisai

Money Control, 2 months ago
SleekMoney, 4 months ago
American Banking News, 4 months ago
Ticker Report, 4 months ago
FiercePharma, 4 months ago
Zolmax News, 4 months ago
Pharma Letter, 5 months ago
PharmaVOICE, 5 months ago
FiercePharma, 5 months ago
Asian Scientist, 4 months ago

Dr Reddy's may file two new drugs with FDA by 2019

Drug maker Dr Reddy's Laboratories Limited has said that it is currently working on 16 new drug applications and out of which a drug to treat migraines has completed Phase-3 trials and another anti-cancer biologic agent is currently under Phase-3 trials.
 Business Standard4 days ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less